Why did Chemours Co's stock fall despite beating EPS forecasts in Q1 2026?

The stock fell 16.79% in premarket trading and closed at $23.25 despite the EPS beat — reporting $0.05 versus an expected -$0.04 — because of concerns over operational disruptions and overvaluation, even though the company affirmed its expectation to be profitable this year.

What were Chemours Co's Q1 2026 financial results compared to expectations?

Chemours Co reported Q1 2026 earnings of $0.05 per share, beating the forecasted loss of -$0.04, while revenue came in at $1.4 billion, meeting expectations.

Earnings Call Transcript: Chemours Co Q1 2026 Beats EPS Forecast, Stock Falls

May 6, 2026

Chemours Co beat Q1 2026 EPS forecasts with $0.05 per share while revenue met expectations at $1.4 billion. Shares fell 16.79% due to operational disruption concerns, though management emphasized future profitability and debt reduction strategies.

Investing.com

2026-05-06

The Chemours Company Posts Q1 Adjusted EPS of $0.05, Beating FactSet Estimate

2026-05-06

Chemours Reports First Quarter Results

2026-05-06

Chemours Reports Strong Q1 2026 Earnings, Exceeds Expectations

2026-05-06

Earnings Call Transcript: Chemours Co Q1 2026 Beats EPS Forecast, Stock Falls

2026-05-06

Chemours Announces Second Quarter Dividend